Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma.
Mekhail, Tarek M
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2005 - 832-41 p. digital
Publication Type: Journal Article
0732-183X
10.1200/JCO.2005.05.179 doi
Adult
Aged
Carcinoma, Renal Cell--mortality
Female
Humans
Kidney Neoplasms--mortality
Male
Middle Aged
Prognosis
Survival Rate
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology Feb 2005 - 832-41 p. digital
Publication Type: Journal Article
0732-183X
10.1200/JCO.2005.05.179 doi
Adult
Aged
Carcinoma, Renal Cell--mortality
Female
Humans
Kidney Neoplasms--mortality
Male
Middle Aged
Prognosis
Survival Rate